Ken Griffin Stryker Corp Put Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	SELL	$293.94 - $358.71 $51.7 Million - $63.1 Million	-175,800 Reduced 52.46%	159,300 $57 Million
Q4 2023 Feb 14, 2024	BUY	$253.85 - $299.46 $29.6 Million - $35 Million	116,800 Added 53.5%	335,100 $100 Million
Q3 2023 Nov 14, 2023	BUY	$266.54 - $302.43 $26.7 Million - $30.3 Million	100,100 Added 84.69%	218,300 $59.7 Million
Q2 2023 Aug 14, 2023	SELL	$271.49 - $305.09 $190,043 - $213,562	-700 Reduced 0.59%	118,200 $36.1 Million
Q1 2023 May 15, 2023	SELL	$246.13 - $285.47 $18.8 Million - $21.8 Million	-76,300 Reduced 39.09%	118,900 $33.9 Million

Q4 2022 Feb 14, 2023	SELL	$205.51 - $253.93 $30.9 Million - $38.2 Million	-150,300 Reduced 43.5%	195,200 $47.7 Million
Q3 2022 Nov 14, 2022	BUY	$189.27 - $231.83 $39.4 Million - $48.3 Million	208,300 Added 151.82%	345,500 $70 Million

2,130

280M

1.19M

710K

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $128B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.